tiprankstipranks
Adaptimmune Enhances Severance Benefits for Executives
Company Announcements

Adaptimmune Enhances Severance Benefits for Executives

Don't Miss our Black Friday Offers:

Adaptimmune Therapeutics (ADAP) has issued an update.

Adaptimmune Therapeutics plc updated their executive severance policy, enhancing the benefits for terminated executives. Now, if an executive is let go without cause or leaves for a valid reason, they’ll get a year’s salary and healthcare premiums for the same duration, with the possibility of a prorated annual bonus. In cases of company control changes within 12 months, similar severance terms apply, along with accelerated equity awards vesting. The CEO gets even better terms, with 18 months of salary and health benefits, and a bonus based on target goals. These benefits are contingent on a claims release and adherence to post-employment agreements.

See more data about ADAP stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyAdaptimmune price target lowered to $3 from $4 at Guggenheim
TheFlyAdaptimmune price target lowered to $3.50 from $4 at H.C. Wainwright
TipRanks Auto-Generated NewsdeskAdaptimmune’s Strategic Shift and Financial Update
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App